Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Holding ELAN?
Track your performance easily
ELAN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.52 - $18.80
Previous Close$15.09
Volume3.60M
Average Volume (3M)5.34M
Market Cap
$7.59B
Enterprise Value$12.85B
Total Cash (Recent Filing)$416.00M
Total Debt (Recent Filing)$5.68B
Price to Earnings (P/E)―
Beta1.77
Next Earnings
Nov 05, 2024EPS Estimate
$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.55
Shares Outstanding494,325,065
10 Day Avg. Volume3,683,919
30 Day Avg. Volume5,344,584
Standard Deviation0.13
R-Squared0.29
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.99
Price to Sales (P/S)1.69
Price to Cash Flow (P/CF)9.50
P/FCF Ratio7.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.86
Enterprise Value/Gross Profit5.17
Enterprise Value/Ebitda-42.54
Forecast
1Y Price Target
$19.57Price Target Upside29.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Elanco Animal Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceElanco’s 2Q sales of $1,184 and Adj EPS of 30c were comfortably ahead of BofAe/Street.
Product LaunchElanco remains optimistic about Zenrelia's blockbuster potential and its contribution to the innovative portfolio.
Revenue And GrowthThe company raised its new product outlook this year and reiterated the 2025 new product outlook.
Bears Say
Product SafetyZenrelia received a black-box label warning from the FDA, creating challenges.
ProfitabilityStepped up expenses associated with launches in 2025 are anticipated, impacting profitability dynamics.
Revenue ExpectationsRevenue expectations for Zenrelia have been lowered by 50% across 2024-2027 due to concerns about the black box warning.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $8.52 and its highest was $18.80 in the past 12 months.
What is Elanco Animal Health’s market cap?
Currently, no data Available
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is Nov 05, 2024 which is in 58 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on Aug 08, 2024. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.06.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is $0.13.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 494,325,070 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.3 in its last earnings report, beating expectations of $0.24. Following the earnings report the stock price went up 4.927%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Among the largest hedge funds holding Elanco Animal Health’s share is Dodge & Cox. It holds Elanco Animal Health’s shares valued at 1B.
---
Elanco Animal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.57 (29.69% Upside)
$19.57 (29.69% Upside)
Blogger Sentiment
Bullish
ELAN Sentiment 75%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 18.8%
Last 30 Days ▲ 18.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.06%
12-Months-Change
Fundamentals
Return on Equity
-18.78%
Trailing 12-Months
Asset Growth
-12.86%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.
---
ELAN Company Deck
---
ELAN Earnings Call
Q2 2024
0:00 / 0:00
---
ELAN Stock 12 Month Forecast
Average Price Target
$19.57
▲(29.69% Upside)
Technical Analysis
Best Analysts Covering ELAN
1 Year
1 Year Success Rate
11/14 ratings generated profit
1 Year Average Return
+19.63%
assigned a buy rating last month
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 78.57% of your transactions generating a profit, with an average return of +19.63% per trade.
---